Harfst & Associates Inc. reduced its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) by 1.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,503 shares of the medical research company’s stock after selling 47 shares during the […]
Oxler Private Wealth LLC cut its position in Amgen Inc. (NASDAQ:AMGN – Get Rating) by 3.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 12,237 shares of the medical research company’s stock after selling 401 shares during the period. Amgen makes up about 1.7% of Oxler Private […]
StockNews.com cut shares of Amgen (NASDAQ:AMGN – Get Rating) from a strong-buy rating to a buy rating in a report released on Wednesday morning. Other equities analysts have also recently issued research reports about the company. Wells Fargo & Company raised Amgen from an equal weight rating to an overweight rating and lowered their target […]
First City Capital Management Inc. increased its stake in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) by 5.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,017 shares of the medical research company’s stock after acquiring an additional 213 shares during […]
Seeyond cut its position in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) by 13.0% during the 4th quarter, Holdings Channel reports. The firm owned 19,752 shares of the medical research company’s stock after selling 2,942 shares during the quarter. Seeyond’s holdings in Amgen were worth $5,188,000 as of its most recent filing with the […]